Etomidate for critically ill patients. Con: do you really want to weaken the frail?

De la Grandville, Béatrice; Arroyo, Diego Andoni; Walder, Bernhard (2012). Etomidate for critically ill patients. Con: do you really want to weaken the frail? European journal of anaesthesiology, 29(11), pp. 511-514. Lippincott Williams & Wilkins 10.1097/EJA.0b013e32835819ca

[img] Text
Etomidate_EJA.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (116kB) | Request a copy

Etomidate is an imidazole-derived hypnotic agent preferentially used for rapid sequence induction of anaesthesia because of its favourable haemodynamic profile. However, 11β-hydroxylase inhibition causes adrenal insufficiency with potentially fatal consequences in specific populations. We review the arguments against the liberal administration of etomidate in critically ill, and especially septic, patients. This review considered only high-quality and prospective studies with a low risk of bias. Three major effects have been observed with the clinical use of a single dose of etomidate. First, independent of the clinical setting, etomidate causes adrenal dysfunction via 11β-hydroxylase inhibition ranging from 12 to 48 h, making the drug unsuitable for use in elective interventions. Second, in a systematic review with meta-analyses, including 3715 septic patients, the relative risk of death with etomidate was 1.22 (95% confidence interval 1.11 to 1.35). Based on this statistically significant and clinically relevant increase in mortality, a single dose of etomidate has to be avoided in patients with septic shock. Third, in small randomised controlled trials, a single dose of etomidate in trauma patients was associated with an increased incidence of pneumonia (56.7 vs. 25.9% in controls), prolonged intensive care stay (6.3 vs. 1.5 days) and prolonged hospital stay (11.6 vs. 6.4 days). Based on these randomised controlled trials, the use of etomidate should be avoided in unstable trauma patients. Midazolam and ketamine are two valid alternatives with similar intubation and haemodynamic conditions as etomidate but without its adverse effects. Therefore, for safety reasons, etomidate should be avoided in the critical conditions of sepsis and trauma

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Arroyo, Diego Andoni

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0265-0215

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Diego Andoni Arroyo

Date Deposited:

09 Oct 2014 10:27

Last Modified:

09 Dec 2014 10:00

Publisher DOI:

10.1097/EJA.0b013e32835819ca

BORIS DOI:

10.7892/boris.59147

URI:

https://boris.unibe.ch/id/eprint/59147

Actions (login required)

Edit item Edit item
Provide Feedback